The results of a phase 3 trial suggest that a targeted therapy, known as sacituzumab tirumotecan (sac-TMT), was associated with a lower risk of progression and death of endometrial cancer.
Researchers from SKUAST-K and Saudi Arabia’s University of Tabuk found that compounds from two Himalayan medicinal plants ...
A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for ...
San Francisco 49ers tight end George Kittle is using his grandfather’s experience with prostate cancer to encourage men to ...
Explore integrative therapies for metastatic prostate cancer, including nutrition, acupuncture, supplements, exercise, and ...
A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for ...
AstraZeneca has punted a pair of early-phase prostate cancer progra | AstraZeneca has punted a pair of early-phase prostate ...
Adding the drug darolutamide to hormone treatment and radiation reduced the risk of prostate cancer spreading or death in a large trial of patients at very high risk of recurrence. An interim analysis ...
A new ASTRO clinical guideline recommends moderately shortened radiation schedules for all risk groups of localized prostate ...
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based ...
The update replaces ASTRO’s 2018 recommendations to reflect the growing body of evidence showing that hypofractionated ...
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results